{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:06:38Z","timestamp":1787900798561,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,15]]},"DOI":"10.7759\/cureus.69450","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:47:25Z","timestamp":1726408045000},"source":"Crossref","is-referenced-by-count":8,"title":["A Review on the Role of SNCA Gene in Neurodegenerative Diseases"],"prefix":"10.7759","author":[{"given":"Afrarahamed","family":"Jahabardeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirenjen","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanan","family":"J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310809","article-title":"Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis","volume":"24","author":"Ciurea AV","year":"2023","unstructured":"Ciurea AV, Mohan AG, Covache-Busuioc RA, Costin HP, Glavan LA, Corlatescu AD, Saceleanu VM. Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis. Int J Mol Sci. 2023, 24:10809. 10.3390\/ijms241310809","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1601567","article-title":"Genetic forms of Parkinson's disease","volume":"37","author":"Kim CY","year":"2017","unstructured":"Kim CY, Alcalay RN. Genetic forms of Parkinson's disease. Semin Neurol. 2017, 37:135-46. 10.1055\/s-0037-1601567","journal-title":"Semin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101648","article-title":"What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?","volume":"79","author":"Fern\u00e1ndez-Santiago R","year":"2022","unstructured":"Fern\u00e1ndez-Santiago R, Sharma M. What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?. Ageing Res Rev. 2022, 79:101648. 10.1016\/j.arr.2022.101648","journal-title":"Ageing Res Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-dynuclein induced synaptopathy in Parkinson's disease","volume":"12","author":"Bridi JC","year":"2018","unstructured":"Bridi JC, Hirth F. Mechanisms of \u03b1-dynuclein induced synaptopathy in Parkinson's disease. Front Neurosci. 2018, 12:80. 10.3389\/fnins.2018.00080","journal-title":"Front Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228645","article-title":"The role of \u03b1-synuclein oligomers in Parkinson's disease","volume":"21","author":"Du XY","year":"2020","unstructured":"Du XY, Xie XX, Liu RT. The role of \u03b1-synuclein oligomers in Parkinson's disease. Int J Mol Sci. 2020, 21:8645. 10.3390\/ijms21228645","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi P","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023, 14:176. 10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.78","article-title":"\u03b1-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism","volume":"1","author":"Rodr\u00edguez-Leyva I","year":"2014","unstructured":"Rodr\u00edguez-Leyva I, Calder\u00f3n-Garcidue\u00f1as AL, Jim\u00e9nez-Capdeville ME, et al.. \u03b1-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism. Ann Clin Transl Neurol. 2014, 1:471-8. 10.1002\/acn3.78","journal-title":"Ann Clin Transl Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052285","article-title":"\u03b1-Synuclein and anti-\u03b1-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls","volume":"7","author":"Smith LM","year":"2012","unstructured":"Smith LM, Schiess MC, Coffey MP, Klaver AC, Loeffler DA. \u03b1-Synuclein and anti-\u03b1-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls. PLoS One. 2012, 7:e52285. 10.1371\/journal.pone.0052285","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.11.001","article-title":"Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease","volume":"81","author":"Nishioka K","year":"2020","unstructured":"Nishioka K, Hashizume Y, Takanashi M, et al.. Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease. Parkinsonism Relat Disord. 2020, 81:183-7. 10.1016\/j.parkreldis.2020.11.001","journal-title":"Parkinsonism Relat Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026159","article-title":"SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate \u03b1-synuclein and are susceptible to oxidative stress","volume":"6","author":"Byers B","year":"2011","unstructured":"Byers B, Cord B, Nguyen HN, et al.. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate \u03b1-synuclein and are susceptible to oxidative stress. PLoS One. 2011, 6:e26159. 10.1371\/journal.pone.0026159","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.11.003","article-title":"Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study","volume":"396","author":"Mej\u00eda M","year":"2019","unstructured":"Mej\u00eda M, Rodr\u00edguez-Leyva I, Cort\u00e9s-Enr\u00edquez F, Chi-Ahumada E, Portales-P\u00e9rez DP, Mac\u00edas-Islas MA, Jim\u00e9nez-Capdeville ME. Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study. J Neurol Sci. 2019, 396:87-93. 10.1016\/j.jns.2018.11.003","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00684-5","article-title":"Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the prodromal stage","volume":"12","author":"Bousiges O","year":"2020","unstructured":"Bousiges O, Philippi N, Lavaux T, et al.. Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the prodromal stage. Alzheimers Res Ther. 2020, 12:120. 10.1186\/s13195-020-00684-5","journal-title":"Alzheimers Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181434","article-title":"Feasibility and safety of multicenter tissue and biofluid sampling for \u03b1-synuclein in Parkinson's disease: the Systemic Synuclein Sampling Study (S4)","volume":"8","author":"Chahine LM","year":"2018","unstructured":"Chahine LM, Beach TG, Seedorff N, et al.. Feasibility and safety of multicenter tissue and biofluid sampling for \u03b1-synuclein in Parkinson's disease: the Systemic Synuclein Sampling Study (S4). J Parkinsons Dis. 2018, 8:517-27. 10.3233\/JPD-181434","journal-title":"J Parkinsons Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda T","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT, et al.. Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology. 2010, 75:1766-72. 10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01388","article-title":"Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson's disease","volume":"10","author":"Chang CW","year":"2019","unstructured":"Chang CW, Yang SY, Yang CC, Chang CW, Wu YR. Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson's disease. Front Neurol. 2019, 10:1388. 10.3389\/fneur.2019.01388","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12494","article-title":"The presence of alpha-synuclein in skin from melanoma and patients with Parkinson's disease","volume":"4","author":"Rodriguez-Leyva I","year":"2017","unstructured":"Rodriguez-Leyva I, Chi-Ahumada E, Mej\u00eda M, et al.. The presence of alpha-synuclein in skin from melanoma and patients with Parkinson's disease. Mov Disord Clin Pract. 2017, 4:724-32. 10.1002\/mdc3.12494","journal-title":"Mov Disord Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.10.003","article-title":"Therapeutic approaches to target alpha-synuclein pathology","volume":"298","author":"Brundin P","year":"2017","unstructured":"Brundin P, Dave KD, Kordower JH. Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol. 2017, 298:225-35. 10.1016\/j.expneurol.2017.10.003","journal-title":"Exp Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2017.07.018","article-title":"Distinct \u03b1-Synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies","volume":"109","author":"Peng C","year":"2018","unstructured":"Peng C, Gathagan RJ, Lee VM. Distinct \u03b1-Synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies. Neurobiol Dis. 2018, 109:209-18. 10.1016\/j.nbd.2017.07.018","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/life11080804","article-title":"The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson's disease","volume":"11","author":"Magistrelli L","year":"2021","unstructured":"Magistrelli L, Contaldi E, Comi C. The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson's disease. Life (Basel). 2021, 11:804. 10.3390\/life11080804","journal-title":"Life (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.4.3.361","article-title":"Biomarker identification in neurologic diseases: improving diagnostics and therapeutics","volume":"4","author":"Coon KD","year":"2004","unstructured":"Coon KD, Dunckley T, Stephan DA. Biomarker identification in neurologic diseases: improving diagnostics and therapeutics. Expert Rev Mol Diagn. 2004, 4:361-75. 10.1586\/14737159.4.3.361","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286599-a-review-on-the-role-of-snca-gene-in-neurodegenerative-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:47:31Z","timestamp":1726408051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286599-a-review-on-the-role-of-snca-gene-in-neurodegenerative-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.69450","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,15]]}}}